Flynn Pharma

Showing 4 posts of 4 posts found.

pfizer_chrome_plate

Pfizer successfully appeals 2,600% price hiking case

June 8, 2018
Medical Communications Flynn Pharma, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer and co-defendant Flynn Pharma have won their appeal against a £90 million fine imposed on them by the Competition …

Pfizer slapped with record £84.2 million fine for 2,600% price increase

December 7, 2016
Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine

Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …

pfizerbrussels

Pfizer fined for epilepsy drug price increase by UK antitrust regulator

April 15, 2016
Medical Communications CMA, Flynn Pharma, Pfizer, antitrust, competition and markets authority, epilepsy, fine, flynn

Pfizer has been fined for unfairly increasing the price of epilepsy drug Epanutin (phenytoin sodium) by the UK Competition and …

Pfizer and Flynn rapped for overcharging on anti-epilepsy drug

August 6, 2015
Manufacturing and Production, Sales and Marketing CMA, Drug pricing, Flynn Pharma, Pfizer, competitions markets authority, epilepsy, generics, phenytoin, pricing

Pharma firms Pfizer and Flynn Pharma have been accused by the UK’s competition watchdog of charging ‘excessive and unfair’ prices …

Latest content